top of page
Automated Vaccine Production

Our Manufacturing Facilities

Our two state-of-the-art facilities are designed for aseptic fill-finish, lyophilization, and high-potency containment, compliant with US FDA

Pearl River, New York

  • Former Wyeth/Pfizer facility leased for a period of 10 + 10 years

  • Five (5) operational lines

  • FDA approved in 2022 (first inspection) and in 2024 (second inspection)

  • Manufacturing capabilities:

    • Sterile dry powder vials

    • Solutions and suspensions in PFS

    • Solutions and suspensions in Vials up to 250 mL

    • Sterile ophthalmic solutions and suspensions

East Windsor, New Jersey

  • New under-construction site

bottom of page